Linaclotide for Colonoscopy Bowel Preparation
Use of Linaclotide as a single agent Colonoscopy prep
Prevention Study
Summary
Study start date: December 1, 2025
Actual date on which the first participant was enrolled.This study is exploring the use of Linaclotide, a medication already approved for treating chronic constipation and irritable bowel syndrome, as a possible new method for preparing the bowel before a colonoscopy. Colonoscopy is a procedure that requires a clean bowel to give doctors a clear view. Traditionally, bowel preparation involves drinking large volumes of liquid solutions, which can be uncomfortable. Researchers are investigating whether Linaclotide can effectively prepare the bowel on its own, potentially reducing the amount of liquid a patient needs to drink before the procedure. This could make the preparation process more comfortable for patients. Participants in this study will receive Linaclotide as the only agent to prepare their bowels for a colonoscopy. The medication works by speeding up the movement through the intestine and increasing fluid in the bowel, helping to clear it out. The study will assess how well Linaclotide cleans the bowel and whether it provides a clear enough view for the colonoscopy. The aim is to see if Linaclotide can be a stand-alone preparation method, which could simplify and improve the experience for patients undergoing this important screening procedure.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.10 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 65 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Inclusion Criteria: * Adult male and female patients (age 18 years to 65) admitted, who are scheduled for a colonoscopy during their admission. Exclusion Criteria: * Pregnant patients * Patients with weight less than 116 pounds * Patients with prior colon resection surgeries * Presence of colostomy * Patients undergoing sigmoidoscopy or pouchoscopy * Patients unable to swallow pills/tablets * Patients who would use a G or J feeding tubes to administer medications/preparation regimen * Patients who are unable to consent for themselves * Patients with a history of renal failure * Patients already taking Linaclotide * Patients who experienced hypersensitivity reactions to Linaclotide in the past
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location